Nl-Fr

View abstract

This abstract is assigned to session Poster Session - On Display Posters nr 200 ... 299
Presentation preference Oral presentation
TitleSAFETY OF INTRAVENOUS METHYLPREDNISOLONE IN REFRACTORY AND SEVERE PEDIATRIC UVEITIS
PurposeTo evaluate the safety of intravenous high-dose pulse methylprednisolone succinate (IVHDM) in the management of severe or refractory non-infectious pediatric uveitis.
MethodsWe reviewed all uveitis patients who were ≤16 years of age and who received IVHDM with a dose of ≥500 mg per day (1–3 days a month) for at least 3 months during their management at a tertiary care eye hospital.
ResultsTwenty pediatric patients with severe or refractory uveitis who received IVHDM were identified. Six patients were excluded, the remaining 14 patients received IVHDM for at least 4 months. Age (mean±SD) was 11.9±2.4 years and 50% were female. Duration of treatment was 14.2±7.5 months. Thirteen patients received IVHDM in combination with other immunomodulatory therapy. Except for two outliers, IVHDM was given at a dose of 8–25 mg/kg per infusion. Three major adverse events (AEs) occurred in two patients and the number of AEs (major and minor) strongly correlated with duration of treatment (p=0.004) and moderately correlated with the cumulative dose/weight (p=0.051).
ConclusionIVHDM may be a valid therapeutic option for aggressive/refractory pediatric uveitis. The reported AEs in this series can also be attributed to the concurrent IMT or the underlying disease itself.
Conflict of interestNo
Authors 1
Last nameSENDINO TENORIO
first name(s)I
DepartmentComplejo Asistencial Universitario de León
CityLeón
CountrySpain
Authors 2
Last nameGhoraba
first name(s)H
Departmentpencer Center for Vision Research, Byers Eye Institute, Stanford University
CityPalo Alto
CountryUnited States
Authors 3
Last nameMatsumiya
first name(s)W
Departmentpencer Center for Vision Research, Byers Eye Institute, Stanford University
CityPalo Alto
CountryUnited States
Authors 4
Last nameKhojasteh
first name(s)H
Departmentpencer Center for Vision Research, Byers Eye Institute, Stanford University
CityPalo Alto
CountryUnited States
Authors 5
Last nameAkhavanrezayat
first name(s)A
Departmentpencer Center for Vision Research, Byers Eye Institute, Stanford University
CityPalo Alto
CountryUnited States
Authors 6
Last nameKaraca
first name(s)I
Departmentpencer Center for Vision Research, Byers Eye Institute, Stanford University
CityPalo Alto
CountryUnited States
Authors 7
Last nameOr
first name(s)C
Departmentpencer Center for Vision Research, Byers Eye Institute, Stanford University
CityPalo Alto
CountryUnited States
Authors 8
Last nameYavari
first name(s)N
Departmentpencer Center for Vision Research, Byers Eye Institute, Stanford University
CityPalo Alto
CountryUnited States
Authors 9
Last nameDo
first name(s)D
Departmentpencer Center for Vision Research, Byers Eye Institute, Stanford University
CityPalo Alto
CountryUnited States
Authors 10
Last nameDong Nguyen
first name(s)Q
Departmentpencer Center for Vision Research, Byers Eye Institute, Stanford University
CityPalo Alto
CountryUnited States